Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 6 of 271 Results
Age
Type
Conditions or Disease:

PhIII StudyEvaluating Giredestrant+Everolimust Compare w/Exemestane+Everolimus Pts ER+HER2-Breast Ca

Ritesh Parajuli

  • OPEN TO ACCRUAL

PhIII TeclistamabMonother VSPomalidomide Bortezomib/Carfilzomib Dexamethasone RelapOR Refr MultiMyel

Lisa Xingguang Lee

  • IRB INITIAL APPROVAL

Long Term Follow Up Patients Previously Tx w/ Mustang Bio, Inc. CAR-T Cell Investigational Products

Susan O'Brien

  • OPEN TO ACCRUAL

Ph I CA-4948 in Comb w/ Gemcitabine and Nab-Paclitaxel in Meta or UnresePancreatic Ductal Carcinoma

Farshid Dayyani

  • OPEN TO ACCRUAL